Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Biomaterials. 2015 Dec 29;82:94–112. doi: 10.1016/j.biomaterials.2015.12.025

Fig. 2.

Fig. 2

Schematic of a protein therapy design. An effective therapy requires the elucidation of the pathological changes after MI, leading to the identification of involved proteins. It is also essential to develop a proper delivery technology that can encapsulate proteins of interest and deliver them in a physiologic manner. The optimized strategy can potentially counter or reverse the pathological progression and trigger the repair and regeneration mechanisms in the heart.